Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
biotech
clinical trials
fda
national
2019
activism
acute hepatic porphyria
aimmune therapeutics
allergy
ambys medicines
amicus therapeutics
ampio pharmaceuticals
anaphylaxis
andrew oxtoby
What
drug
3
×
therapy
3
×
approval
bio
fda
gene
roundup
treat
advanced
agency
aimmune
allergy
alnylam’s
approved
aren’t
awarded
bff
conference
deals
developed
developers
devoted
disease
drugs
easl
form
friday
help
imminent
immunotherapy
kicked
late
liver
long
major
medicare
moves
news
noteworthy
oral
Language
unset
Current search:
therapy
×
drug
×
" seattle blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More